$131.67 +0.47 (%) Valeant Pharmaceuticals International Inc - NYSE

Oct. 1, 2014 | 04:00 PM

Partner Headlines

  1. Deal Frenzy: 2014 Sees Record M&A Volume

    FoxBusiness | Sep. 30, 2014 | 00:00AM EST
  2. Tax Inversions Help Push Global M&A To 7-Year High

    IBD | Sep. 29, 2014 | 18:33PM EST
  3. Large-Cap Tech, Biotech Names Hang Tough In Shaky Market

    IBD | Sep. 29, 2014 | 18:32PM EST
  4. Rebound Efforts Fade For Stocks; Synchronoss Clears Resistance

    IBD | Sep. 29, 2014 | 13:32PM EST
  5. UPDATE: Allergan Board Offers Statement, Says Valeant's Bid 'Grossly Inadequate'

    Benzinga | Sep. 29, 2014 | 08:05AM EST
  6. Jackson Square Partners Joins Investors Opposing Allergan Bid for Salix

    Benzinga | Sep. 28, 2014 | 11:05AM EST
  7. Facebook Among 5 IBD 50 Stocks Holding Near Highs

    IBD | Sep. 27, 2014 | 08:02AM EST
  8. Meet 5 Top Stocks With Rising Earnings Estimates

    IBD | Sep. 26, 2014 | 08:02AM EST
  9. Glaucoma Drug Lifts Valeant

    IBD | Sep. 25, 2014 | 18:53PM EST
  10. Valeant: Glaucoma Drug Is Potential Blockbuster

    IBD | Sep. 25, 2014 | 13:47PM EST
  11. Apple Fuels Tech Sell-Off; Valeant Bucks The Trend

    IBD | Sep. 25, 2014 | 11:34AM EST
  12. Benzinga's M&A Chatter for Wednesday September 24, 2014

    Benzinga | Sep. 24, 2014 | 21:09PM EST
  13. Pharma Buyout Bids Beat On

    IBD | Sep. 24, 2014 | 18:55PM EST
  14. Valeant Ends Prince Charming Act; Allergan Hopes Rise

    IBD | Sep. 24, 2014 | 15:55PM EST
  15. Ackman forewarns Allergan

    IBD | Sep. 23, 2014 | 18:45PM EST
  16. Benzinga's M&A Chatter for Tuesday September 23, 2014

    Benzinga | Sep. 23, 2014 | 18:35PM EST
  17. Stocks Fall To Session Lows; Vipshop Bucks The Trend

    IBD | Sep. 23, 2014 | 15:00PM EST
  18. Allergan-Ackman Flame War Reignites On Salix Rumors

    IBD | Sep. 23, 2014 | 11:47AM EST
  19. Indexes Pare Losses As Salix Soars On Buyout Talk

    IBD | Sep. 23, 2014 | 10:56AM EST
  20. Stock Futures Lower, But Salix Soars On Buyout Talk

    IBD | Sep. 23, 2014 | 08:55AM EST
  21. Salix Pharmaceuticals, Ltd. Set To Be Acquired By Allergan, Inc.

    Benzinga | Sep. 22, 2014 | 22:50PM EST
  22. Benzinga's M&A Chatter for Monday September 22, 2014

    Benzinga | Sep. 22, 2014 | 18:17PM EST
  23. Valeant, Allergan settle suit

    IBD | Sep. 16, 2014 | 18:53PM EST
  24. Valeant, Allergan Settle Suit, Allow Shareholder Vote

    IBD | Sep. 16, 2014 | 11:36AM EST
  25. Ackman's New Fund Could Spur More Market Activism

    IBD | Sep. 15, 2014 | 12:22PM EST
  26. Pershing Square Submiterd Additional Special Meeting Requests On Friday, Total Submitted Represents 35.68% Of Allergan Shares

    Benzinga | Sep. 15, 2014 | 11:57AM EST
  27. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD | Sep. 13, 2014 | 08:02AM EST
  28. William Ackman Sends Letter To Allergen Board

    Benzinga | Sep. 9, 2014 | 15:56PM EST
  29. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD | Sep. 5, 2014 | 17:06PM EST
  30. Valeant Pharmaceuticals Part XII: the rolling solvency calculation

    GuruFocus | Sep. 2, 2014 | 10:23AM EST
  31. Allergan Reports Filing of Answer in Federal Court Related to Valeant, Pershing Square's Counterclaims

    Benzinga | Sep. 2, 2014 | 09:04AM EST
  32. Hedge Fund Manager Bill Ackman with a Very Profitable Year

    GuruFocus | Aug. 28, 2014 | 10:59AM EST
  33. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD | Aug. 27, 2014 | 08:02AM EST
  34. IBD's Special 8-Week Hold Rule Has Faced Tough 2014

    IBD | Aug. 21, 2014 | 17:34PM EST
  35. SALIX PHARMACEUTICALS

    IBD | Aug. 20, 2014 | 18:56PM EST
  36. Benzinga's M&A Chatter for Tuesday August 19, 2014

    Benzinga | Aug. 19, 2014 | 19:31PM EST
  37. Salix Soars On Allergan Buzz

    IBD | Aug. 19, 2014 | 18:50PM EST
  38. Indexes Rally On Strong Housing Data, Retail Reports

    IBD | Aug. 19, 2014 | 17:03PM EST
  39. Allergan Reportedly Eyes Salix To Avoid Valeant Deal

    IBD | Aug. 19, 2014 | 14:28PM EST
  40. Allergan Takes In 13 New Hedge Fund Investments In Q2

    Benzinga | Aug. 15, 2014 | 13:20PM EST
  41. Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension Improving

    Benzinga | Aug. 14, 2014 | 16:37PM EST
  42. Benzinga's M&A Chatter for Monday August 11, 2014

    Benzinga | Aug. 11, 2014 | 19:11PM EST
  43. Valeant Pharmaceuticals'

    IBD | Aug. 11, 2014 | 18:49PM EST
  44. Valeant Pharmaceuticals Part X: a follow up on the sale of facial injectables

    GuruFocus | Aug. 11, 2014 | 09:38AM EST
  45. Allergan Rebounds After Analyst Upgrades On Valuation

    IBD | Aug. 8, 2014 | 12:23PM EST
  46. Prescription Drugmakers Slide Down Industry Rankings

    IBD | Aug. 4, 2014 | 18:35PM EST
  47. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD | Aug. 2, 2014 | 08:02AM EST
  48. Thursday's Selling Momentum Continues In To Friday

    Benzinga | Aug. 1, 2014 | 16:33PM EST
  49. Thursday's Selling Momentum Continues Into Friday

    Benzinga | Aug. 1, 2014 | 16:33PM EST
  50. Valeant, Ackman's Pershing Square Issue Response to 'Frivolous Allergan Lawsuit'

    Benzinga | Aug. 1, 2014 | 15:02PM EST
Trading Center